Showing results (2651-2660 of 3,662) with videos related to

Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|February 10, 2024
Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02)Claire Phillips, Mark B Pinkham, Alisha Moore, et al.
Breast (Edinburgh, Scotland)|February 15, 2024
Seizing the moment: The time for harnessing electronic patient-reported outcome measures for enhanced and sustainable metastatic breast cancer care is nowK M de Ligt, L B Koppert, B H de Rooij, et al.
Breast (Edinburgh, Scotland)|January 26, 2024
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?Xuhui Guo, Jiao Zhang, Xilong Gong, et al.
Breast (Edinburgh, Scotland)|August 4, 2023
The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic reviewKeris Poelhekken, Yixuan Lin, Marcel J W Greuter, et al.
Breast (Edinburgh, Scotland)|July 30, 2023
Differences between the efficacy of HER2(2+)/FISH-positive and HER2(3+) in breast cancer during dual-target neoadjuvant therapyWei Chen, Fen-Xiang Li, Da-Lin Lu, et al.
Breast (Edinburgh, Scotland)|April 8, 2026
Chemotherapy is associated with differential survival outcomes in apocrine carcinoma: A nationwide cohort study from the Japanese National Clinical Database-Breast Cancer RegistryYoshiya Horimoto, Hiraku Kumamaru, Kyoko Orimoto, et al.
Breast (Edinburgh, Scotland)|April 8, 2026
Real-world progression-free survival 2 (PFS2) and tumor response of CDK4/6 inhibitors plus an aromatase inhibitor in patients with HR+/HER2- metastatic breast cancer in US routine clinical practiceHope S Rugo, Adam Brufsky, Rachel M Layman, et al.
Breast (Edinburgh, Scotland)|April 14, 2026
Association between diarrhea and survival in patients with HER2-positive advanced breast cancer treated with pyrotinib-based therapy: A landmark analysis from the real-world PRETTY studyYiqun Li, Wenna Wang, Zhongsheng Tong, et al.
Breast (Edinburgh, Scotland)|April 7, 2026
Global patterns and risk factors of breast cancer in women under 35: a population-based studyDechuang Jiao, Jiujun Zhu, Dandan Wang, et al.
Breast (Edinburgh, Scotland)|May 2, 2024
Prediction of breast cancer and axillary positive-node response to neoadjuvant chemotherapy based on multi-parametric magnetic resonance imaging radiomics modelsYingyu Lin, Jifei Wang, Meizhi Li, et al.
Pageof 367